| Schedule of Computation of Basic and Diluted Earnings Per Share |
The following table summarizes the computation of basic and diluted income (loss) per share for the three and six months ended June 30, 2026 and 2025. | | | | | | | | | | | | | | | | | | | | | | | | | | | | (Net income (loss) in thousands) | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | | Basic income (loss) per share: | | | | | | | | | | Net income (loss) attributable to Common shareholders | $ | 143 | | | $ | (5,001) | | | $ | (1,612) | | | $ | (7,778) | | | | Divided by: | | | | | | | | | | Weighted average shares outstanding | 117,479,316 | | 78,123,095 | | 117,283,603 | | 45,885,468 | | | | | | | | | | | | Basic income (loss) per share of common stock | $ | 0.00 | | | $ | (0.06) | | | $ | (0.01) | | | $ | (0.17) | | | | | | | | | | | | | Diluted income (loss) per share: | | | | | | | | | | Net income (loss) attributable to Common shareholders | $ | 143 | | | $ | (5,001) | | | $ | (1,612) | | | $ | (7,778) | | | | | | | | | | | | | Weighted average shares outstanding | 117,479,316 | | 78,123,095 | | 117,283,603 | | 45,885,468 | | | | | | | | | | | | Effect of potentially dilutive restricted shares of common stock | — | | (1) | — | | (2) | — | | (3) | — | | (4) | | | | | | | | | | | Divided by: | | | | | | | | | | Weighted average diluted shares outstanding | 117,479,316 | | 78,123,095 | | 117,283,603 | | 45,885,468 | | | | | | | | | | | | Diluted income (loss) per share of common stock | $ | 0.00 | | | $ | (0.06) | | | $ | (0.01) | | | $ | (0.17) | | |
| | | | | | | (1) | | The weighted average diluted shares outstanding does not include 887,433 anti-dilutive restricted shares of common stock for the three months ended June 30, 2026. | | (2) | | The weighted average diluted shares outstanding does not include 4,597,710 anti-dilutive restricted shares of common stock for the three months ended June 30, 2025. | | (3) | | The weighted average diluted shares outstanding does not include 1,315,833 anti-dilutive restricted shares of common stock for the six months ended June 30, 2026. | | (4) | | The weighted average diluted shares outstanding does not include 5,119,740 anti-dilutive restricted shares of common stock for the six months ended June 30, 2025. | | | | |
|